Further in vitro cell adhesion assays should pre-treat cell suspensions with an LHRRVKI-containing peptide at various concentrations to determine the involvement of the heparin-binding domain in human cancer cell adhesion to BSP. The gene discussed is IBSP; the disease is cancer.